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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYIn the adult brain, self-renewal is essential for the persistence of neural stem cells (NSCs) throughout life, but its regulation is still poorly
understood. One NSC can give birth to two NSCs or one NSC and one transient progenitor. A correct balance is necessary for the main-
tenance of germinal areas, and understanding the molecular mechanisms underlying NSC division mode is clearly important. Here, we
report a function of the Sonic Hedgehog (SHH) receptor Patched in the direct control of long-termNSC self-renewal in the subependymal
zone. We show that genetic conditional activation of SHH signaling in adult NSCs leads to their expansion and the depletion of their
direct progeny. These phenotypes are associated in vitro with an increase in NSC symmetric division in a process involving NOTCH
signaling. Together, our results demonstrate a tight control of adult neurogenesis and NSC renewal driven by Patched.INTRODUCTION
Neural stem cells (NSCs) remain in specialized niches of the
brain over the lifespan and give rise to new neurons that
integrate neural circuits. They are proposed to enable regen-
erationof injured tissue. The subependymal zone (SEZ), one
of the main neurogenic niches in the adult mammalian
brain, is comprised of astrocyte-like NSCs corresponding
to a heterogeneous cell population. Among the identified
subpopulations, active NSCs (aNSCs) expressing the
epidermal growth factor receptor (EGFR) give rise to transit
amplifying progenitors (TAPs). Most of these cells generate
neuroblasts, migrating along the rostral migratory stream
(RMS) and differentiating into granule and periglomerular
interneurons in the olfactory bulb (OB). Quiescent NSCs
(qNSCs) do not express the EGFR and are resistant to anti-
mitotic drugs or irradiation. They are implicated in SEZneu-
rogenesis replenishment through aNSCs and TAPs (Costa
et al., 2011; Pastrana et al., 2011; Ponti et al., 2013). Estab-
lishing the identity and lineage of SEZ stem cells is under
intense studies, but the regulatory mechanisms involved
in their self-renewal and differentiation still need more
investigation. Only a few signals determining these distinct
behaviors have been discovered. For instance, bone
morphogenetic protein signals and EGFR-mediated inacti-
vation of NOTCH signaling in NSCs are required for pro-
gression of theNSC progeny toward the neurogenic lineage
(Aguirre et al., 2010; Colak et al., 2008), whereas the
pigment epithelium-derived factor was proposed to regu-
late the NSC expansion (Karpowicz et al., 2009).312 Stem Cell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The AutThe Sonic Hedgehog (SHH) pathway is active in the
adult SEZ, where it has been proposed to regulate cell
proliferation (Ruat et al., 2012; Ahn and Joyner, 2005;
Machold et al., 2003) and to modulate the migration of
neuroblasts exiting the niche (Angot et al., 2008). The
mosaic inactivation of the Smoothened (SMO) receptor
in cell types expressing the neuroepithelial marker
NESTIN suggested the requirement of this transducer of
SHH signal for maintenance of the NSC population (Ba-
lordi and Fishell, 2007). Patched (PTC) is the main SHH
receptor and is considered an antagonist of the pathway
(Briscoe and The´rond, 2013). Embryonic deletion of Ptc
in multipotent stem cells of human glial fibrillary acidic
protein (hGFAP)-Cre;PtcC/C mice results in medulloblas-
toma. The tumors do not manifest until the cells have
committed to the neuronal lineage (Yang et al., 2008).
However, the effects of Ptc inactivation in adult NSCs of
the SEZ remain yet unknown.
Here, we used a tamoxifen-inducible Cre transgene un-
der the control of the astrocyte-specific glutamate trans-
porter (GLAST) expressed in astrocyte-like NSCs (Mori
et al., 2006) and took advantage of a conditional Ptc
knockout (Ptcfl/fl) mouse line that has loxP recombinase
recognition sites within the Ptc gene (Uhmann et al.,
2007). We show that Ptc inactivation in the adult NSCs
leads to a dramatic decrease of the neurogenic process
and to a marked expansion of NSCs in the SEZ. Neurogen-
esis blockade was related to a shift in NSC division
mode from asymmetric to symmetric, leading to a decrease
in the differentiation process and involving NOTCHhors
Figure 1. Inducible Deletion of Ptc in
GLAST-Expressing Cells from the Adult
Brain SEZ
(A) Immunohistofluorescence (IHF) indi-
cating the presence of a population of PTC+
cells (green) coexpressing the astroglial
marker GFAP (red) in the dorsal SEZ. Mag-
nifications of the boxed areas are presented
below each panel.
(B) Double IHF performed on brain slices
from the heterozygous Ptc+/LacZ mouse that
expresses the LACZ reporter in one allele of
Ptc. Anti-b-GAL (red) and GLAST (green)
antibodies are used. Magnifications of the
area indicated by arrowheads are presented
below each panel and show b-GAL+ nuclei
surrounded (white arrowheads) or not (black
and white arrowhead) by GLAST+ signal.
(C) Fluorescent signals of YFP together
with GLAST and GFAP in the SEZ of
Glast-CreERT2;R26R-YFP (YFP-control) mice
2 months after tamoxifen administration.
The white arrow indicates a cell coexpress-
ing YFP with alternatively GLAST or GFAP
markers and magnified in the inset. Nuclei
are in blue (DAPI) in (A)–(C).
(D) In situ hybridization (ISH) of two HH target genes, Ptc and Gli1, in the SEZ of mice in which Ptc exons 8 and 9 are flanked by loxP sites.
In Ptc/ (Glast-CreERT2;Ptcfl/fl) mice, exons 8 and 9 were depleted by tamoxifen-mediated activation of Glast-CreERT2 that is expressed
from the endogenous Glast locus. Tamoxifen-treated Ptcfl/flmice served as controls (control). Two months after tamoxifen treatment, the
animals were subjected to analysis. The Ptc del riboprobe encompasses nucleotides of Ptc exons 8 and 9 and thus detects only the WT Ptc
transcripts. The Ptc riboprobe corresponds to half of the full-length Ptc transcript, including the C-terminal end. In the control mice, Ptc
del, Ptc, and Gli1 allow the detection of the faint labeling previously reported in the SEZ with a stronger signal in the ventral niche. In
Ptc/mice, strong Ptc and Gli1 signals are detected in the ventral and dorsal SEZ, whereas no signal is observed when the Ptc del riboprobe
is used.
CPu, caudate putamen; Cx, cerebral cortex; LV, lateral ventricle; Sp, septal area. Scale bars, 50 mm (A and B), 100 mm (C), and 200 mm (D).
See also Figures S1 and S2.
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adult NSC self-renewal mechanisms.RESULTS
Conditional Deletion of Ptc in GLAST-Expressing Cells
Promotes Endogenous Activation of HH Signaling in
the SEZ Niche
To investigate the role of PTC in NSCs of the adult SEZ
niche, we used a genetic approach aimed at conditionally
deleting this receptor in the astroglial population in
which we formerly demonstrated its expression (Figure 1;
Figure S1 available online). Ptc transcripts and proteins
were evidenced in the SEZ niche. Confocal analysis using
a specific PTC antiserum (Bidet et al., 2011; Figure S1)
showed PTC expression in a subset of GFAP+ cells
(36% ± 5%) (Figure 1A). Moreover, analysis of the
Ptc+/LacZ mice (Goodrich et al., 1997) led to visualizingStem Cb-galactosidase (b-GAL+)/PTC+ cells coexpressing GLAST,
a marker of astrocyte-like NSCs (Figure 1B). Therefore,
we took advantage of the Glast-CreERT2 mouse line
(Mori et al., 2006) expressing a tamoxifen-inducible Cre
in the locus of Glast to induce Cre recombinase activity
specifically in adult astroglia and NSCs. Glast-CreERT2
mice were crossed with the Rosa26 reporter line, R26R-
YFP (yellow fluorescent protein) (Srinivas et al., 2001).
In the Glast-CreERT2;PtcWT/WT;R26R-YFP offspring (so-
called YFP-control), YFP expression is initiated upon
tamoxifen-mediated activation of the Cre recombinase
and permanently marks all progeny of the recombined
cells. At 2 months after tamoxifen treatment, a high num-
ber of YFP+ cells are detected in the SEZ that coexpress the
astrocyte markers GLAST and GFAP (Figure 1C). Confocal
analysis of the SEZ niche indicated that YFP reporter is ex-
pressed in 85% ± 5% of GLAST+ cells. Recombination also
occurred in neurogenic astroglial-like cells of the hippo-
campal subgranular zone and in other astrocyteell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Authors 313
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expression profile (Mori et al., 2006) (Figure S2A).
Ptc was inactivated in GLAST+ cells by crossing alterna-
tively the Glast-CreERT2 or YFP-control with Ptcfl/fl mouse
lines allowing the excision of exons 8 and 9 encoding a
domain involved in SHH binding (Uhmann et al., 2007).
Adult Glast-CreERT2;Ptcfl/fl (so-called Ptc/) mice and
littermate Ptcfl/fl controls (so-called control) were treated
with tamoxifen and analyzed 10 days, or 2, 6, or 12months
later. Despite a loss of bodyweight in Ptc/ animals treated
with tamoxifen 1 year before, their brain was macroscopi-
cally indistinguishable from the brain of the controls.
Notably, no tumor could be detected (data not shown).
Analyses of Gli1 or Ptc transcription were used as readouts
of Hedgehog (HH) pathway activation (Briscoe and The´r-
ond, 2013). In Ptc/mice, both genes were highly upregu-
lated in ventral and dorsal SEZs, indicating a sustained acti-
vation of HH signaling compared to controls. Additional
control experiments demonstrated the specificity of both
Gli1 and Ptc transcription in Ptc/ animals (Figure 1D;
see Figures S2B and S2C). Altogether, these results demon-
strate that Cre-mediated recombination allows the efficient
deletion of Ptc in GLAST+ cells, leading to the persistent
activation of HH signaling in the adult SEZ niche.
Ptc Deletion Affects Both Fast and Slow Proliferation
and Decreases Neurogenesis
To determine the functional meaning of Ptc deletion in
GLAST+ cells in the SEZ, we first examined fast proliferating
cells (TAPs and neuroblasts) by administrating to the ani-
mals two bromodeoxyuridine (BrdU) pulses at 2 hr inter-
vals. Pulsing was done at various time points (10 days,
and 2, 6, and 12months) after tamoxifen injection. The an-
imals were sacrificed after the last BrdU pulse (Figures 2A
and 2B). In control animals, BrdU+ cell number decreases
between 2 and 6 months after treatment, presumably re-
flecting a regular decline associated with aging as previ-
ously shown by Shook et al. (2012). Interestingly, BrdU+
cells were significantly decreased in the SEZ of Ptc/
mice when compared to controls over the course of the
study. At 10 days, the 27% decrease was already highly sig-
nificant and reached 54% at 2 months. The drop in fast
proliferating cells was still observed after 6 months and
led to their almost complete disappearance at 1 year in
Ptc/ animals, likely related to both the observed pheno-
type and the regular decrease occurring in aging. We
excluded cell survival decrease because the number of ter-
minal deoxynucleotidyl transferase dUTP nick end label-
ing-positive cells was not significantly modified in Ptc/
SEZs over the course of the study (Figure S3). Remarkably,
the SEZ visualization of EGFR+ cells corresponding to
TAPs and a low percentage of transitional stages (Pastrana
et al., 2011; Ponti et al., 2013) revealed a dramatic 93%314 Stem Cell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Autdecrease of this cell population at 12months in the Ptcmu-
tants (Figures 2C and 2D). Polysialylated-neuronal cell
adhesion molecule (PSA-NCAM+)-positive cell number
was reduced by more than 90% in Ptc/ mice, which is
consistent with a high rate of Ptc excision in these animals,
resulting in the quite complete absence of SEZ-migrating
neuroblasts (Figures 2C and 2D). In contrast, the density
of Gfap+ cells that correspond to astrocytes and NSCs in
the SEZ showed a robust 62% increase in Ptc/ animals
analyzed at 12 months (Figures 2E and 2F).
Consistently, at 2months, quantification of SEZ cell pop-
ulations indicated that the Ptc deletion increases by almost
2-fold the number of GLAST+ cells corresponding to both
niche astrocytes and NSCs, and the number of KI67+/
GFAP+ NSCs. TAPs and neuroblasts were decreased by
2-fold as indicated by EGFR and PSA-NCAM stainings (Fig-
ures 2G and 2H). Moreover, in the absence of Ptc, we found
amarked increase in the number of sex-determining region
Y-box 2+ (SOX2+) and SOX9+ cells both expressed in NSCs
and TAPs (Kazanis et al., 2010; Scott et al., 2010). Because
the TAP population is reduced, the increase in SOX2+ and
SOX9+ cells may consistently reflect the increase of NSC
density. Together, these data show that the Ptc deletion is
thus associated with an increase in the number of astro-
cyte-like NSCs in the SEZ and a decrease in the number of
TAPs and migrating neuroblasts.
The progeny of the recombined cells was traced by
following the expression of YFP in Glast-CreERT2;Ptcfl/fl;
R26R-YFP (so-called YFP-Ptc/) and YFP-control mice
treated with tamoxifen and analyzed 2months later. As ex-
pected, strong YFP signals were detected in the SEZ-RMS-
OB system of YFP-control mice (Figure 3A) and also in
the corpus callosum (cc), where they reflect both the pop-
ulation of newly generated oligodendroglial cells derived
from the SEZ (Gonzalez-Perez and Alvarez-Buylla, 2011)
and the local GLAST-expressing astroglial cells present in
the fiber tracts (Figure S4A). In YFP-Ptc/ animals, YFP
expression level was dramatically affected except in the
SEZ, where the density of YFP+ cells was only slightly
reduced without reaching significance (Figure 3B). The
apparent divergence between the unaltered YFP+ cell den-
sity and the substantial reduction in the number of BrdU+
cells in the SEZ may be explained for the former by a
compensatory mechanism between the increase in NSCs
and the decrease in TAPs/neuroblasts and for the latter by
the collapse of the dynamics of TAPs and neuroblasts.
Indeed, TAPs have been proposed to divide three times
before turning into neuroblasts and neuroblasts once or
twice before leaving the SEZ (Ponti et al., 2013). In YFP-
Ptc/ animals, quantification of YFP+ cells in the OB gran-
ular (GrO) and glomerular (Gl) layers (Figure 3B; see also
Figures S4A–S4C) and in the cc (Figures S4D–S4F) indicated
a 69%, 36%, and 51% decrease, respectively. Interestingly,hors
Figure 2. Alteration of Cell Proliferation
and Phenotype in the Adult SEZ/RMS
upon Ptc Deletion
(A) Detection of fast proliferating cells by
IHF using anti-BrdU antibody in brain slices
of Ptc/ and control animals treated 1 year
before with tamoxifen and analyzed 2 hr
after short BrdU pulses.
(B) Histogram depicting the number of
BrdU+ and GFAP+ cells quantified in the SEZ
at the indicated time after tamoxifen
treatment.
(C and D) IHF visualizing the expression of
EGFR (red) and PSA-NCAM (green) in the SEZ
of control and Ptc/ mice 1 year after
tamoxifen administration and quantifica-
tion.
(E and F) ISH showing the Gfap gene
expression in the SEZ of control and Ptc/
mice 1 year after tamoxifen administration
and quantification for the various time
points.
(G) Fluorescent micrographs in the adult
SEZ of control and Ptc/ mice 2 months
after tamoxifen administration. The micro-
graphs depict immunostainings for GLAST
and GFAP/KI67 as astrocyte and stem cell
markers, SOX2 and SOX9 as transcription
factors necessary for NSC formation, and
EGFR and PSA-NCAM as markers of TAPs and
migrating neuroblasts, respectively. In the
last panels, BrdU labels the fast prolifer-
ating cell populations. The dashed lines
delineate the wall of the lateral ventricle
except for the last two panels on the right
where they delineate the cc.
(H) Histograms describing the number of
each cell type per square millimeter. Values
are the mean ± SEM from three to four
animals, two to four slices per animal.
CPu, caudate putamen; LV, lateral ventricle.
*p% 0.05; **p% 0.005; ***p% 0.0005.
Scale bars, 100 mm (A and G), 25 mm (GFAP/
KI67 pictures in G), and 50 mm (C and E).
See also Figure S3.
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and superficial layers with, however, a slightly higher
decrease in the deep layer. Thus, Ptc deletion affects both
the ventral and dorsal parts of the SEZ known to contribute
to the production of deep and superficial granule cells,
respectively. This suggests that SHH signaling displays a
broader effect than initially proposed alongside the whole
SEZ (Ihrie et al., 2011). Moreover, the fluorescent signal
was also dramatically reduced in the RMS connecting the
SEZ to the OB (Figure 3A).Stem CBecause these results indicated a decrease in the genera-
tion of new cells in the SEZ, we further analyzed the pheno-
type of SEZ-derived cells at their final destinations: the OB
(Figures 3C and 3D), and the cc (Figure S4C). In the GrO
layer of the OB where the newly generated cells mature as
GABAergic interneurons, the percentage of YFP+ cells ex-
pressing the neuronal marker NEUN or C-FOS, a transcrip-
tion factor rapidly regulated by neuronal activity, was
unchanged in Ptc/ mice. These data indicated that there
was no difference in the proportion of neurons fullyell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Authors 315
Figure 3. Cell Fate Analysis after Dele-
tion of Ptc in the Adult SEZ
(A) Tracing of Glast+ cells in YFP-Ptc/ and
YFP-control mice treated with tamoxifen
2 months before. YFP is detected in the SEZ,
RMS, and OB. A lower density of YFP+ cells is
observed in the RMS and OB of YFP-Ptc/
mice compared to YFP-controls. In contrast,
no difference is observed in the SEZ.
(B) Quantification of the density of YFP+
cells in the SEZ and OB layers.
(C) Phenotype of the targeted cells at their
final destination upon conditional Ptc
deletion in the SEZ. IHF (NEUN, C-FOS, CB,
and TH) or ISH (v-Glut2) in slices from YFP-
control or YFP-Ptc/ mice at the level of
the OB is shown. White arrowheads indicate
double-labeled cells.
(D) Histogram presenting the percentage of
each cell phenotype within the YFP popu-
lation.
(E) Brain slices performed at the level of
the OB from control and Ptc/ mice
treated with tamoxifen 1 year before and
stained with hematoxylin and eosin (H&E).
No alteration of the multilayered cellular
architecture of the OB is observed. Values
are the mean ± SEM from three to four
animals, two to four slices per animal.
**p % 0.005; ***p % 0.0005. Scale bars,
50 mm (A and C) and 200 mm (E).
See also Figure S4.
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Genetic Deletion of Patched in Neural Stem Cellsintegrated into the GrO layer. We then analyzed the per-
centage of YFP+ cells expressing tyrosine hydroxylase
(TH), calbindin, or vesicular glutamate transporter 2
(vGlut2), which labels subsets of SEZ-derived new cells inte-
grating theGl layer (Brill et al., 2009). In the conditional Ptc316 Stem Cell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Autmutants, the percentage of newly generated calbindin+
cells was not significantly modified. In contrast, the per-
centages of YFP+ cells coexpressing either TH or vGlut2
were 3-fold higher or lower, respectively. Remarkably,
at 1 year post tamoxifen, the multilayered cellularhors
Figure 4. Sustained HH Signaling Activa-
tion in SEZ-Derived Neural Progenitors
Maintains NSC Multipotency in the Neu-
rosphere Assay
(A and B) SEZ neurospheres derived from
Ptc/ mice analyzed 2 months after
tamoxifen administration can be expanded
in a similar manner as controls and
display Gli1 upregulation. The neurosphere
numbers obtained at each passage were
analyzed via a linear regression model. The
rate of clonal expansion is represented as
the slope of the lines (Ptc/ 0.256 ± 0.047
versus control 0.226 ± 0.016; p > 0.05).
(C) Large sphere number (>100 mm in
diameter) is slightly, but significantly,
higher in Ptc/ compared to controls (p =
0.03). Values are expressed as the per-
centage of the total number of spheres
generated from 5,000 plated cells (total
counted spheres: n = 138 for Ptc/, n = 98
for controls).
(D) Evaluation of the expression of progen-
itor cell markers (SOX2, SOX9, and NESTIN)
in cells dissociated from neurospheres and
then cultured for 12 hr in the absence of
growth factors. Quantification of each cell
type indicates a significant increase in the number of SOX9+ and NESTIN+ cells. The mean numbers of counted cells per marker are 227 ± 67
and 356 ± 147 for Ptc/ and controls, respectively.
(E–G) Histograms depicting the differentiation potential of neurospheres from Ptc/ and control mice cultured for 7 days without growth
factors in the absence or the presence of pharmacological HH modulators, including the SMO agonist SAG (0.3 mM) and antagonist MRT-83
(3 mM). Differentiated cells were analyzed by IHF using TUJ1, GFAP, and OLIG2 antibodies to characterize neuronal (E), astroglial (F),
and oligodendroglial (G) cells, respectively. In the absence of drugs, a significant decrease in the percentage of TUJ1+ and OLIG2+ cells
is observed in Ptc/ compared to control cells. The mean numbers of counted cells for each marker are 1,699 ± 309 and 3,822 ± 128 for
Ptc/ and controls, respectively. The data are expressed as the mean ± SEM of the percentage of DAPI+ nuclei, which express each marker
and are derived from three independent experiments.
*p% 0.05; **p% 0.01; ***p% 0.005; ns, nonsignificant. Scale bar, 100 mm.
See also Figure S5.
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to control (Figure 3E). In the cc, a 2-fold lower proportion
of YFP+ cells expressing OLIG2 was observed in YFP-Ptc/
animals (Figure S4C), suggesting that Ptc deletion decreases
the ability of precursor cells to give rise to oligodendro-
cytes. As a whole, these data establish that the generation
of new precursors is highly decreased in the SEZ of the con-
ditional Ptc mutants. Although these precursors still have
the ability to differentiate into neurons and oligodendro-
cytes in the OB and cc, respectively, they nevertheless
display discrete variations of fate determination.
Ptc Deficiency in SEZ-Derived Neural Progenitors
Changes Cell Differentiation Capacity in the
Neurosphere Assay
To address the consequences of Ptc deficiency in SEZ pro-
genitors, we used the neurosphere culture to analyzeStem Cstem and progenitor cell properties between Ptc-deficient
and control cells (Pastrana et al., 2011).We observed no dif-
ference in sphere formation of cells derived from Ptc/
SEZs 2months after tamoxifen injection, despiteGli1 upre-
gulation observed in Ptc-deficient neurospheres (Figures 4A
and 4B). The clonal expansion represented as the slope of
the line indicated that Ptc deficiency does not alter the
apparent capacity of self-renewal of the neurospheres.
However, when we quantified the subpopulations of neu-
rospheres according to their diameter, we observed a higher
number of large neurospheres (R100 mm) derived from the
Ptc/ SEZ (Figure 4C). This observation may suggest that
more stem cells are present in Ptc-deficient spheres because
it was previously proposed that aNSCs give rise to large
spheres, whereas progenitors lead to smaller ones (Pastrana
et al., 2011). This is also consistent with a decrease in TAPs
in the SEZ of these animals as previously observed.ell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Authors 317
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in the absence of growth factors, significantly more cells
were positive for SOX9 in the Ptc-deficient neurospheres
when compared to the controls (Figure 4D; see also Fig-
ure S5A), consistent with our in vivo data and also with
the upregulation of SOX9 observed upon HH activation
(Scott et al., 2010). In contrast, SOX2 expression did not
significantly differ between the groups, whereas the num-
ber of NESTIN+ neuroepithelial cells was increased by 1.6-
fold, indicating that the Ptc deficiency has inhibited differ-
entiation. To further evaluate the multipotency of Ptc/
NSCs, the neurospheres were cultured for 7 days in the
absence of growth factors to allow differentiation into neu-
rons, oligodendrocytes, and astrocytes. Although Ptc/
NSCsmaintain their multipotency, their ability to differen-
tiate wasmodified (Figures 4E–4G; see also Figure S5B). The
percentage of TUJ1+ neuroblasts and OLIG2+ oligodendro-
cytes (only OLIG2+ GFAP cells were counted to avoid
including immature OLIG2+ GFAP+ astrocytes as previ-
ously reported in Marshall et al., 2005) was significantly
reduced in Ptc-deficient cells, whereas the number of
GFAP+ astrocytes was not modified by the Ptc deletion.
Then, we addressed the question whether the effects
observed above in Ptc-deficient cells could be modulated
through SMO (Figures 4E–4G). In agreement with the
involvement of SMO activation in Ptc/ phenotype, the
number of TUJ1+ neuroblasts, OLIG2+ oligodendrocytes,
and GFAP+ astrocytes was reduced in cells derived from
control mice upon addition of Smoothened agonist
(SAG), a reference SMO activator (Chen et al., 2002). In
contrast, application of the SMO antagonist MRT-83 (Rou-
daut et al., 2011) did not modify the generation of any cell
types, suggesting that HH signaling is already antagonized
by PTC. However, application of MRT-83 increased the ca-
pacity of Ptc/ cells to differentiate into neuroblasts, oligo-
dendrocytes, and astrocytes. Thus, the rescue of the Ptc/
phenotype by SMO blockade is likely associated with the
relief of PTC constitutive inhibitory effect on SMO. Impor-
tantly, Ptc deficiency decreases the total number of
cells reaching the differentiated state, although it does
not prevent cells from achieving terminal multilineage
differentiation.
Ptc Deficiency in SEZ-Derived Neural Progenitors
Promotes Symmetric GLAST+/EGFR NSC Pairs
through NOTCH Signaling and Reduces Cell-Cycle
Exit of TAPs
The inactivation of Ptc in GLAST+ cells in the adult SEZ re-
sulting in an increase of NSCs prompted us to investigate
the potential crosstalk between HH and NOTCH signaling,
which has been shown to regulate cell cycle to balance NSC
maintenance during corticogenesis (Dave et al., 2011) and
to be essential for the maintenance of NSCs (Aguirre et al.,318 Stem Cell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Aut2010; Imayoshi et al., 2013). First, we used the clonal pair
cell assay adapted from the previously described protocol
of Dave et al. (2011). We plated primary cells directly after
their isolation from the SEZ, and we maintained them in
culture 24–36 hr to allow cell division. We used GLAST
and EGFR antibodies to label the stem cells and their direct
progeny, respectively. SEZ-derived cells isolated from wild-
type (WT) mice were treated with the SMO agonist SAG in
the presence or absence of the inhibitor of g-secretase,
LY411575, which suppresses proteolysis-dependent activa-
tion of endogenous NOTCH receptors (Fauq et al., 2007).
SAG significantly promotes symmetric GLAST+/EGFR
pairs at the expense of GLAST+/EGFR+ pairs compared to
the basal condition. The SAG-mediated effect was counter-
acted by LY411575 treatment as well as by the SMO antag-
onist MRT-83 (Figures 5A and 5B). This indicates that HH-
dependent generation of symmetric GLAST+/EGFR pairs,
likely corresponding to an activated state of NSCs different
from those that are GLAST+/EGFR+, is also NOTCH depen-
dent. Then, we performed semiquantitative RT-PCR anal-
ysis in SVZ-derived neurospheres from conditional Ptc/
and control animals treated with tamoxifen for 2 months.
Notch1 and two of its canonical effectors, the transcription
factors Hes1 and Hes5 (Imayoshi et al., 2013), are upregu-
lated when Ptc is conditionally deleted (Figure 5C). These
data indicate that the NOTCH signaling pathway is acti-
vated upon Ptc deletion.
We next tested if the above-reported effect on symmetric
GLAST+/EGFRNSCs observed upon pharmacological acti-
vation of SMO could be observed upon genetic deletion of
Ptc in the adult NSCs. In cell cultures derived from Ptc/
mice that received a tamoxifen injection 2 months before,
a 4- to 5-fold increase of symmetric GLAST+/EGFR pairs
was detected at the expense of both the asymmetric pairs
and symmetric GLAST+/EGFR+ pairs compared to the con-
trols (Figures 5D and 5E). Thus, Ptc deficiency in adult SEZ-
derived NSCs favors the generation of symmetric GLAST+/
EGFRNSCs. The absence of significant decrease in the per-
centage of symmetric GLAST+/EGFR+ pairs suggests that
the pharmacological activation of SMO in WT neuro-
spheres is not fully comparable to the genetic deletion of
Ptc regarding the mechanism of self-renewal of GLAST+/
EGFR NSCs and aNSCs.
We determined the proportion of precursor cells labeled
by a 2 hr pulse of BrdU in the population of cycling cells ex-
pressing KI67 in vivo in the SEZ of animals that received
tamoxifen 2months before. A 2 hr pulse of BrdU essentially
reflects the proliferation of aNSCs, TAPs, and neuroblasts
(Ponti et al., 2013). This protocol led us to determine that
the labeling index was not modified by Ptc inactivation
(Figures 5F and 5G). We also evaluated the number of cells
exiting the cell cycle when animals were killed 24 hr after
BrdU injection. The quantification of the number ofhors
Figure 5. Ptc Deficiency Increases NSC
Symmetric Division by Upregulating the
NOTCH Pathway
(A) The clonal paired-cell assay is per-
formed on SEZ-derived cells isolated from
WT animals. The cells are cultured for 24–
36 hr in the presence of the indicated drugs.
SAG, LY, and MRT-83 were used at 0.3, 10,
and 3 mM, respectively. The paired cells are
labeled using GLAST (green) and EGFR (red)
as markers of NSCs and TAPs, respectively.
Nuclei are in blue (DAPI).
(B) Quantitative analysis of the percentage
of each type of division indicates that SAG
significantly increases the number of sym-
metric GLAST+/EGFR pairs compared to the
basal condition. This effect is counteracted
by treatments with the SMO and NOTCH
antagonists, MRT-83 and LY, respectively.
*p% 0.05.
(C) The upregulation of Gli1, Notch1, and
the NOTCH effectors Hes1 and Hes5 is de-
tected by semiquantitative RT-PCR in SEZ-
derived progenitors isolated from adult
Ptc/ mice when compared to control
animals. b-actin was used to assess input
RNA levels.
(D) The clonal paired-cell assay performed on SEZ-derived precursors isolated from adult Ptc/ and control mice indicates that GLAST-
expressing cells from Ptc/ more frequently generate two GLAST+ precursors after 24–36 hr when compared to control cultures.
(E) Quantitative analysis.
(F) BrdU (red) and KI67 (green) labeling of SEZ slices derived from Ptc/ and control mice that had received tamoxifen 2 months before
and were analyzed 2 or 24 hr after a single BrdU injection. The yellow fluorescence corresponds to double-labeled cells. In the bottom
panels, the white arrowheads indicate the BrdU+KI67 cells.
(G and H) The histograms show the percentage of BrdU+ cells in the population of cycling cells 2 hr after the BrdU pulse (G) and the
percentage of BrdU+ cells that left the cell cycle (KI67) 24 hr after the BrdU pulse (H). Values are mean ± SEM from three to four animals,
two to four slices per animal.
(I) Labeling index of cycling cells (i.e., the percentage of KI67+ cells that have incorporated BrdU) in control and Ptc/ SEZ-derived cells.
The equations of the linear regressions for each group indicate no significant difference in the slopes and consequently similar cell-cycle
lengths. For cell cultures, values are mean ± SEM from three experiments.
**p% 0.01. Scale bars, 25 mm (A), 50 mm (D), and 100 mm (F). LY, LY411575.
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BrdU incorporation (cells that are still KI67+) showed that
a nearly 2-fold lower percentage of Ptc-deficient cells exit
the cell cycle when compared to the control (Figure 5H).
By using the BrdU cumulative approach, we also addressed
the question of a potential difference in the cell-cycle
length of NSCs when Ptc is deleted. We cultured SEZ-
derived cells from animals treated with tamoxifen
5 months earlier. Taking into account our in vivo results,
at that time point, SEZ cells of Ptc/ animals correspond
to a majority of aNSCs because TAPs and neuroblasts
have collapsed. Under such conditions, a shortening of
cell-cycle length resulting in an increase in NSC prolifera-
tion should be clearly detected because aNSCs were re-
ported to display the shortest cell-cycle length comparedStem Cto neuroblasts and TAPs with values close to 17, 18, and
18–25 hr, respectively (Ponti et al., 2013). The cell-cycle
length obtained in Ptc/ culture is slightly but nonsignifi-
cantly shorter (14.2 hr) compared to the control cultures
(16.2 hr), thus suggesting that the NSC proliferation is
likely not increased (Figure 5I). Altogether, these data indi-
cate that Ptc deficiency likely lowers the number of fast
proliferating cells exiting the cell cycle and, thus, their abil-
ity to differentiate but does not increase aNSC proliferation
in vitro.
PTC Is Required for Replenishment of the SEZ Stem
Cell Niche after In Vivo AraC Treatment
Next, we examined in the SEZ of control and Ptc/ animals
treated with tamoxifen 6 months before, the fate of NSCsell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Authors 319
Figure 6. Altered Replenishment of the SEZ Stem Cell Niche in
Conditional Ptc/ Animals after AraC Injury In Vivo
(A and B) Coronal views of the SEZ showing BrdU-incorporating
cells 10 days after pump removal in controls (A) and Ptc/ (B)
animals treated with vehicle or AraC. Animals had received
tamoxifen 6 months before. The white arrowheads indicate BrdU+
nuclei. Scale bars, 100 mm.
(C) Quantification of BrdU-labeled cells in control and Ptc/
animals. Values are themean± SEM from four animals/condition and
two to four slices per animal. ***p% 0.0001; ns, nonsignificant.
See also Figure S6.
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kills dividing NSCs, TAPs, and proliferating neuroblasts
while sparing qNSCs. After transient impairment of neuro-
genesis by AraC treatment, the damaged SEZ is then regen-
erated by astrocyte-like NSCs resulting in the increase of
cell proliferation and the production of aNSCs and TAPs
(Pastrana et al., 2011). Immediately after AraC treatment
(day 0), cells that incorporated BrdU were mostly missing,320 Stem Cell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Autwhereas 10 days later (day 10), BrdU+ cell population re-
turned to normal in the control SEZ when compared to
vehicle treatment (Figures 6A and 6C; see also Figure S6).
However, the number of BrdU+ cells in the Ptc/ SEZ was
3-fold lower after AraC compared to vehicle treatment (Fig-
ures 6B and 6C). These data indicate that, upon AraC treat-
ment, Ptc deficiency prevents qNSCs to be activated and to
give rise to TAPs. Thus, PTC is required for effective regen-
eration after lesion in the SEZ.DISCUSSION
Conditional Ptc inactivation in the adult NSCs allowed the
study of HH signaling activation in a ligand-independent,
cell-intrinsic fashion in the SEZ in vivo. This activation is
likely due to the suspension of the inhibitory effect of
PTC on SMO and may promote the generation of symmet-
ric GLAST+/EGFR pairs as observed in vitro. Moreover, our
data suggest a likely alteration of the transition from aNSCs
to TAPs, whichmight account for the high decrease of TAPs
and subsequently of neuroblasts. The expression of
NOTCH signaling and high-mobility group box transcrip-
tion factors SOX2 and SOX9, all known to prevent
neuronal differentiation (Scott et al., 2010; Ables et al.,
2011), was also increased. Consistent with the alteration
of the transition between aNSCs and TAPs, we also
observed that the Ptc-deficient NSCs do not regenerate
the SEZ properly after an antimitotic treatment. Neverthe-
less, our data do not allow excluding the potential exis-
tence of additional mechanisms such as, for instance, the
alteration of TAP sensitivity to EGF, whichwould be consis-
tent with the previously reported EGF-mediated induction
of TAP proliferation (Doetsch et al., 2002).
Sustained HH signaling activation in the SEZ of deficient
mice maintains multipotency but influences the fate of
SEZ-derived precursors toward either the oligodendroglial
phenotype in the cc or the glutamatergic and dopami-
nergic phenotypes, two populations of OB periglomerular
interneurons, the specification of whichmay be of high in-
terest in the context of brain repair (Brill et al., 2009; Lledo
et al., 2006). The long-lasting high activation of HH
signaling is still detected 1 year after the recombination.
However, the absence of major alteration of OB
morphology we observed in the present work is consistent
with previous reports showing that adult neurogenesis in
the SEZ allows only a partial turnover of newborn neurons
in the OB (Imayoshi et al., 2008; Ninkovic et al., 2007).
Our results point out a likely interaction betweenHH and
NOTCH signaling pathways in adult neurogenesis, suggest-
ing that both should contribute to properly maintain adult
NSCs, preventing them to become TAPs (Aguirre et al.,
2010; Imayoshi et al., 2013; Kawaguchi et al., 2013). Suchhors
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neurogenic divisions and thus for proper corticogenesis in
development (Dave et al., 2011). The constitutive activa-
tion of HH signaling through Ptc deletion in enteric neural
crest cells also robustly activates NOTCH pathway via Hes1
upregulation and promotes premature gliogenesis, impair-
ing these cells to form ganglia in the hindgut during enteric
nervous system development (Ngan et al., 2011). In agree-
mentwithHH andNOTCH crosstalk in the adult SEZ, NSCs
are both HH (Ahn and Joyner, 2005)- and NOTCH (Aguirre
et al., 2010)-responding cells. If HES transcription factors
are generally regarded as canonical NOTCH pathway effec-
tors (Imayoshi et al., 2013), a NOTCH-independent HH/
HES1 activity was reported in the progenitor cell prolifera-
tion of the retina (Wall et al., 2009). We do not know
whether Hes1 is a direct target of HH signaling in the adult
NSCs, but our results indicate that the effect of active HH
signaling on NSCs is NOTCH dependent. TAPs were re-
ported to regulate NSC self-renewal in vivo, and an interac-
tion between EGFR and NOTCH pathways was proposed to
have selective roles in this process with EGFR being an up-
stream regulator of NOTCH through a nonautonomous
mechanism (Aguirre et al., 2010). Because the conditional
Ptc deletion leads to a huge decrease in EGFR-expressing
TAPs in the SEZ, the subsequent EGFR decrease might
amplify NOTCH signaling induction and thus also partici-
pate in the observed effects. Likewise, SOX9 increase in the
conditional Ptc mutant is consistent with data reporting
that active HH signaling induces Sox9 transcription and re-
sults in the precocious ability of neuroepithelial cells to
form neurospheres (Scott et al., 2010).
Despite PTC characterization as a tumor suppressor
(Goodrichetal., 1997),weobserved that its deletion inastro-
cyte-like NSCs increases the stemness of these cells without
promoting tumor formation. Our data are consistent with
the results observed upon the noninducible deletion of Ptc
inGFAP-expressingNSCs, whichwas found to promoteme-
dulloblastomasonlywhenNSCshave committed to granule
neural precursors in the developing cerebellum (Yang et al.,
2008). In contrast with the granule precursors, EGFR+ cells
that comprise TAPs in the SEZ are not expanding upon Ptc
deletion. One explanation is that PTC controls a major
step of NSC maintenance in the SEZ: the lack of its antago-
nist activity on SMO results in a blockade of EGFR+ prolifer-
ative cells, presumably through increasing NSC symmetric
divisions. Further work will have to address if small mole-
cules, positive and negative modulators of SMO that have
been developed (Amakye et al., 2013; Gorojankina et al.,
2013), also regulate NSC stemness in vivo. Consistent with
the present study, recent data have demonstrated that a
major decrease in NSC number accounts for the progressive
loss of neurogenesis in the SEZ of mice upon conditional
ablation of Smo in postnatal GFAP-expressing cells (PetrovaStem Cet al., 2013). By showing the existenceof a PTC-mediated ac-
tivity of SHH in the control of the symmetry or asymmetry
of NSC divisions, our data now provide an answer to the
question addressed by this study regarding the decision-
making process between NSC self-renewal and progenitor
generation. Likewise, though ectopic expression of Gli1
was reported to induce proliferation and transformation of
numerous cell types (Dahmane et al., 1997; Nilsson et al.,
2000), Gli1 upregulation is differently interpreted within
self-renewing NSC context. Such behavior was previously
described in vitro for hippocampus-derived NSCs (Galvin
et al., 2008), which upon Gli1 upregulation, initiate cell-
cycle arrest and apoptosis, interpreted as a defense mecha-
nism against hyperproliferation.
As a whole, our work characterized PTC-mediated signals
as implicated in the physiological regulation of the genera-
tion of NSCs required for sustaining the normal rate of neu-
rogenesis. Instead of promoting precursor cell expansion,
Ptc deletion was associated with a blockade of EGFR+ prolif-
erating cells, leading to an almost disappearance of neuro-
genesis while preserving NSCs. Thus, Glast-CreERT2;Ptcfl/fl
mice should be valuable tools for further investigating
molecular regulation and transductionmechanisms associ-
ated with NSCs in the SEZ in normal and pathological con-
ditions. Thesemice should also be of interest for evaluating
the effect of PTC in NSC maintenance in the subgranular
zone of the hippocampus (Traiffort et al., 2010) and in
astroglia (Sirko et al., 2013).EXPERIMENTAL PROCEDURES
Complete Experimental Procedures are available online (see the
Supplemental Experimental Procedures).
Animals
Eight- to 12-week-old animals were used unless indicated. The
Glast-CreERT2 mouse line (Mori et al., 2006) was received on a
mixed 129 3 C57BL/6 background and backcrossed three times
to C57BL/6. The Ptc floxed/floxed mouse line (Uhmann et al.,
2007) was received and maintained on C57BL/6 background.
The reporter mouse line R26R-YFP/+was a gift from Drs. F. Costan-
tini and T.M. Jessell (Srinivas et al., 2001) kept on C57Bl/6 back-
ground. The Glast-CreERT2 mouse line was crossed to the Ptc
floxed/floxed mouse line. The progeny was then crossed to R26R-
YFP/+ mice genotyped as described by Soriano (1999). All proce-
dures were carried out according to the European Communities
Council Directive (86/806/EEC) and protocols approved by Insti-
tutional Animal Care and Use Committee.
Tamoxifen and BrdU Administration
Tamoxifen (Sigma-Aldrich) was dissolved in corn oil (Sigma-
Aldrich) at 10 mg/ml, and 1 mg was injected intraperitoneally
(i.p.) twice a day for 5 consecutive days. Animals were killed
10 days, or 2, 6, or 12 months after the end of tamoxifenell Reports j Vol. 3 j 312–323 j August 12, 2014 j ª2014 The Authors 321
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Genetic Deletion of Patched in Neural Stem Cellsapplication. In order to label fast proliferating cells, mice received
an i.p. injection of BrdU (Sigma-Aldrich; 100 mg/kg of body
weight) 4 and 2 hr before sacrifice (n = 5–6/group). For the determi-
nation of cell-cycle exit, animals received two BrdU i.p. injections
at 2 hr intervals and were sacrificed 24 hr after the last injection.
Osmotic Minipump Infusion
To kill all fast proliferating cells in the SEZ, AraC (2%; Sigma-
Aldrich) in vehicle (0.9% saline) was infused into the lateral ventri-
cles in control and Ptc/mice that had been injected with tamox-
ifen 6 months earlier. We used miniosmotic pumps (ALZET). After
7 days of infusion, the pumps were removed, and mice were killed
10 days after the end of AraC infusion (n = 4 per condition).
Cannulas were implanted stereotaxically into the lateral ventricle
at the following coordinates: anteroposterior, 0.2 mm; mediolat-
eral, 0.8 mm; and dorsoventral, 2.5 mm (relative to bregma).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and six figures and can be foundwith this article online
at http://dx.doi.org/10.1016/j.stemcr.2014.05.016.
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